F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL

BACKGROUND: Long-stay patients with severe schizophrenia are frequently treated with high doses of first-generation antipsychotics (FGA). Dose reduction or switching to ziprasidone may reduce the severity of negative symptoms or side effects. METHODS: In a randomized double-blind trial, we compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogers, Jan, Schulte, Raphael, Theo, Broekman, de Haan, Lieuwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888017/
http://dx.doi.org/10.1093/schbul/sby017.584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888017/
http://dx.doi.org/10.1093/schbul/sby017.584

Ejemplares similares